"","ID","Description","GeneRatio","BgRatio","pvalue","p.adjust","qvalue","geneID","Count","name"
"R-HSA-110056","R-HSA-110056","MAPK3 (ERK1) activation","1/2","10/10955",0.00182490039463845,0.0184242719487928,0.00163563606393849,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-2465910","R-HSA-2465910","MASTL Facilitates Mitotic Progression","1/2","10/10955",0.00182490039463845,0.0184242719487928,0.00163563606393849,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-8964058","R-HSA-8964058","HDL remodeling","1/2","10/10955",0.00182490039463845,0.0184242719487928,0.00163563606393849,"ALB",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-9757110","R-HSA-9757110","Prednisone ADME","1/2","10/10955",0.00182490039463845,0.0184242719487928,0.00163563606393849,"ALB",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-2514853","R-HSA-2514853","Condensation of Prometaphase Chromosomes","1/2","11/10955",0.00200729876825245,0.0184242719487928,0.00163563606393849,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-2168880","R-HSA-2168880","Scavenging of heme from plasma","1/2","13/10955",0.0023720455159274,0.0184242719487928,0.00163563606393849,"ALB",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-75035","R-HSA-75035","Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex","1/2","13/10955",0.0023720455159274,0.0184242719487928,0.00163563606393849,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-162658","R-HSA-162658","Golgi Cisternae Pericentriolar Stack Reorganization","1/2","14/10955",0.00255439388998779,0.0184242719487928,0.00163563606393849,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-189451","R-HSA-189451","Heme biosynthesis","1/2","14/10955",0.00255439388998779,0.0184242719487928,0.00163563606393849,"ALB",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-189483","R-HSA-189483","Heme degradation","1/2","15/10955",0.00273672559753024,0.0184242719487928,0.00163563606393849,"ALB",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-4419969","R-HSA-4419969","Depolymerization of the Nuclear Lamina","1/2","15/10955",0.00273672559753024,0.0184242719487928,0.00163563606393849,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-1362300","R-HSA-1362300","Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1","1/2","16/10955",0.00291904063855453,0.0184242719487928,0.00163563606393849,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-159418","R-HSA-159418","Recycling of bile acids and salts","1/2","18/10955",0.0032836207210486,0.0184242719487928,0.00163563606393849,"ALB",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-6804114","R-HSA-6804114","TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest","1/2","18/10955",0.0032836207210486,0.0184242719487928,0.00163563606393849,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-2995383","R-HSA-2995383","Initiation of Nuclear Envelope (NE) Reformation","1/2","19/10955",0.00346588576251861,0.0184242719487928,0.00163563606393849,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-176412","R-HSA-176412","Phosphorylation of the APC/C","1/2","20/10955",0.00364813413747078,0.0184242719487928,0.00163563606393849,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-113510","R-HSA-113510","E2F mediated regulation of DNA replication","1/2","22/10955",0.00401258088782053,0.0184242719487928,0.00163563606393849,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-112409","R-HSA-112409","RAF-independent MAPK1/3 activation","1/2","23/10955",0.00419477926321854,0.0184242719487928,0.00163563606393849,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-174048","R-HSA-174048","APC/C:Cdc20 mediated degradation of Cyclin B","1/2","24/10955",0.00437696097209805,0.0184242719487928,0.00163563606393849,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-69273","R-HSA-69273","Cyclin A/B1/B2 associated events during G2/M transition","1/2","25/10955",0.00455912601445962,0.0184242719487928,0.00163563606393849,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-1538133","R-HSA-1538133","G0 and Early G1","1/2","27/10955",0.00492340609962894,0.0184242719487928,0.00163563606393849,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-189445","R-HSA-189445","Metabolism of porphyrins","1/2","27/10955",0.00492340609962894,0.0184242719487928,0.00163563606393849,"ALB",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-69205","R-HSA-69205","G1/S-Specific Transcription","1/2","28/10955",0.00510552114243656,0.0184242719487928,0.00163563606393849,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-8963899","R-HSA-8963899","Plasma lipoprotein remodeling","1/2","34/10955",0.00619786140240264,0.0207309608279454,0.00184041503862546,"ALB",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-3301854","R-HSA-3301854","Nuclear Pore Complex (NPC) Disassembly","1/2","35/10955",0.00637985977958355,0.0207309608279454,0.00184041503862546,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-6804757","R-HSA-6804757","Regulation of TP53 Degradation","1/2","36/10955",0.00656184149024663,0.0207309608279454,0.00184041503862546,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-6806003","R-HSA-6806003","Regulation of TP53 Expression and Degradation","1/2","37/10955",0.00674380653439188,0.0207309608279454,0.00184041503862546,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-5689896","R-HSA-5689896","Ovarian tumor domain proteases","1/2","39/10955",0.00710768662312788,0.0210692139185577,0.00187044384819155,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-2173782","R-HSA-2173782","Binding and Uptake of Ligands by Scavenger Receptors","1/2","42/10955",0.00765338175734609,0.0219045064089561,0.00194459790567777,"ALB",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-9749641","R-HSA-9749641","Aspirin ADME","1/2","44/10955",0.00801709518090132,0.0219519655519635,0.00194881114602085,"ALB",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-194068","R-HSA-194068","Bile acid and bile salt metabolism","1/2","45/10955",0.00819892689290203,0.0219519655519635,0.00194881114602085,"ALB",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-6791312","R-HSA-6791312","TP53 Regulates Transcription of Cell Cycle Genes","1/2","48/10955",0.00874432202979536,0.0226805852647817,0.00201349520422919,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-2980766","R-HSA-2980766","Nuclear Envelope Breakdown","1/2","52/10955",0.00947128221440052,0.0238217098119771,0.00211479985648497,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-9707564","R-HSA-9707564","Cytoprotection by HMOX1","1/2","64/10955",0.0116505627824822,0.0257904926042189,0.00228958082726103,"ALB",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-380259","R-HSA-380259","Loss of Nlp from mitotic centrosomes","1/2","70/10955",0.0127393030745477,0.0257904926042189,0.00228958082726103,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-380284","R-HSA-380284","Loss of proteins required for interphase microtubule organization from the centrosome","1/2","70/10955",0.0127393030745477,0.0257904926042189,0.00228958082726103,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-174184","R-HSA-174184","Cdc20:Phospho-APC/C mediated degradation of Cyclin A","1/2","73/10955",0.013283448222587,0.0257904926042189,0.00228958082726103,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-2299718","R-HSA-2299718","Condensation of Prophase Chromosomes","1/2","73/10955",0.013283448222587,0.0257904926042189,0.00228958082726103,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-8854518","R-HSA-8854518","AURKA Activation by TPX2","1/2","73/10955",0.013283448222587,0.0257904926042189,0.00228958082726103,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-179419","R-HSA-179419","APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint","1/2","74/10955",0.0134647966055638,0.0257904926042189,0.00228958082726103,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-174824","R-HSA-174824","Plasma lipoprotein assembly, remodeling, and clearance","1/2","75/10955",0.0136461283220225,0.0257904926042189,0.00228958082726103,"ALB",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-2995410","R-HSA-2995410","Nuclear Envelope (NE) Reassembly","1/2","75/10955",0.0136461283220225,0.0257904926042189,0.00228958082726103,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-176409","R-HSA-176409","APC/C:Cdc20 mediated degradation of mitotic proteins","1/2","76/10955",0.0138274433719634,0.0257904926042189,0.00228958082726103,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-176814","R-HSA-176814","Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins","1/2","77/10955",0.0140087417553861,0.0257904926042189,0.00228958082726103,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-8852276","R-HSA-8852276","The role of GTSE1 in G2/M progression after G2 checkpoint","1/2","77/10955",0.0140087417553861,0.0257904926042189,0.00228958082726103,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-176408","R-HSA-176408","Regulation of APC/C activators between G1/S and early anaphase","1/2","81/10955",0.0147337686238966,0.0257904926042189,0.00228958082726103,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-380270","R-HSA-380270","Recruitment of mitotic centrosome proteins and complexes","1/2","82/10955",0.014914983674729,0.0257904926042189,0.00228958082726103,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-380287","R-HSA-380287","Centrosome maturation","1/2","82/10955",0.014914983674729,0.0257904926042189,0.00228958082726103,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-174143","R-HSA-174143","APC/C-mediated degradation of cell cycle proteins","1/2","88/10955",0.0160019239828445,0.0258305933951575,0.00229314082138367,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-2565942","R-HSA-2565942","Regulation of PLK1 Activity at G2/M Transition","1/2","88/10955",0.0160019239828445,0.0258305933951575,0.00229314082138367,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-453276","R-HSA-453276","Regulation of mitotic cell cycle","1/2","88/10955",0.0160019239828445,0.0258305933951575,0.00229314082138367,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-5687128","R-HSA-5687128","MAPK6/MAPK4 signaling","1/2","89/10955",0.0161830223680505,0.0258305933951575,0.00229314082138367,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-380320","R-HSA-380320","Recruitment of NuMA to mitotic centrosomes","1/2","94/10955",0.0170882642963102,0.0262652951221064,0.00233173197025675,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-69473","R-HSA-69473","G2/M DNA damage checkpoint","1/2","94/10955",0.0170882642963102,0.0262652951221064,0.00233173197025675,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-5620912","R-HSA-5620912","Anchoring of the basal body to the plasma membrane","1/2","98/10955",0.0178121578415926,0.0268801654700398,0.00238631779695978,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-8957275","R-HSA-8957275","Post-translational protein phosphorylation","1/2","108/10955",0.0196207250485352,0.0290807174826504,0.00258167434849147,"ALB",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-9748784","R-HSA-9748784","Drug ADME","1/2","110/10955",0.0199822384917068,0.0290969437686257,0.00258311485580697,"ALB",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-8878166","R-HSA-8878166","Transcriptional regulation by RUNX2","1/2","121/10955",0.0219693707731109,0.0314389271408311,0.00279102713995964,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-381426","R-HSA-381426","Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)","1/2","125/10955",0.0226914643344431,0.0316395253808987,0.00280883548086608,"ALB",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-2500257","R-HSA-2500257","Resolution of Sister Chromatid Cohesion","1/2","126/10955",0.022871946058481,0.0316395253808987,0.00280883548086608,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-114608","R-HSA-114608","Platelet degranulation ","1/2","129/10955",0.0234132912314866,0.0318266240083015,0.00282544537803564,"ALB",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-69206","R-HSA-69206","G1/S Transition","1/2","131/10955",0.0237741046808999,0.0318266240083015,0.00282544537803564,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-76005","R-HSA-76005","Response to elevated platelet cytosolic Ca2+","1/2","134/10955",0.0243151998561347,0.0320343109215743,0.00284388302410932,"ALB",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-68875","R-HSA-68875","Mitotic Prophase","1/2","141/10955",0.0255771719368838,0.0331703948556462,0.00294474019010175,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-453279","R-HSA-453279","Mitotic G1 phase and G1/S transition","1/2","149/10955",0.0270184257523703,0.0345004513453344,0.00306281749419583,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-8957322","R-HSA-8957322","Metabolism of steroids","1/2","154/10955",0.0279186677252128,0.0351098397150403,0.00311691665193763,"ALB",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-5633007","R-HSA-5633007","Regulation of TP53 Activity","1/2","160/10955",0.028998408097528,0.0359234010760421,0.00318914150326309,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-69481","R-HSA-69481","G2/M Checkpoints","1/2","167/10955",0.0302573468719906,0.0369317616231649,0.00327865987776987,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-69275","R-HSA-69275","G2/M Transition","1/2","196/10955",0.0354642504437672,0.0419156637519983,0.00372111155693073,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-453274","R-HSA-453274","Mitotic G2-G2/M phases","1/2","198/10955",0.0358228305797609,0.0419156637519983,0.00372111155693073,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-9711123","R-HSA-9711123","Cellular response to chemical stress","1/2","199/10955",0.0360020956479807,0.0419156637519983,0.00372111155693073,"ALB",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-5617833","R-HSA-5617833","Cilium Assembly","1/2","201/10955",0.036360575784866,0.0419156637519983,0.00372111155693073,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-68877","R-HSA-68877","Mitotic Prometaphase","1/2","204/10955",0.0368981709913087,0.0419527149627208,0.00372440082104053,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-68882","R-HSA-68882","Mitotic Anaphase","1/2","236/10955",0.0426231866099196,0.0473673456411683,0.00420509092565857,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
"R-HSA-2555396","R-HSA-2555396","Mitotic Metaphase and Anaphase","1/2","237/10955",0.0428018183504533,0.0473673456411683,0.00420509092565857,"CDK1",1,"Upres_DEq_MS_HBV_vs_HBVM"
